1 active not recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow Alkylating Agents: new trials by email Literature Review of Alkylating Agents trials Research Report on Alkylating Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator - Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT) | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 15 | 2010-08-01 | 2026-09-09 |
Desmoplastic Small Round Cell Tumor (1) · Sarcoma (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)